Related Experiment Videos
Cell-free assays for gamma-secretase activity
C McLendon1, T Xin, C Ziani-Cherif
1Department of Pharmacology, Mayo Clinic, Jacksonville, Florida 32224, USA.
Summary
Researchers developed a new in vitro assay to study gamma-secretase activity, crucial for Alzheimer's disease (AD) research. This assay aids in understanding amyloid-beta (Ab) production and developing targeted AD therapeutics.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease (AD) is characterized by amyloid-beta (Ab) deposits.
- Ab is derived from the amyloid-beta precursor protein (APP) via sequential b-secretase and g-secretase cleavages.
Purpose of the Study:
- To develop a robust in vitro assay for gamma-secretase (g-secretase) activity.
- To characterize the properties and pharmacological distinctiveness of g-secretase activity.
Main Methods:
- Development of a de novo Ab production assay in vitro.
- Confirmation of g-secretase activity via cognate g-CTF production and mass spectrometry.
- Inhibition studies using g-secretase modulators.
Main Results:
- The assay accurately monitors authentic g-secretase activity.
- g-secretase activity is membrane-associated but solubilizable.
- Optimal pH is 6.8, with activity from pH 6.0 to >8.4.
- g-secretase activities for Ab40 and Ab42 are pharmacologically distinct.
Conclusions:
- The developed assay facilitates the study of g-secretase.
- Findings support distinct pharmacological profiles for g-secretase activities.
- This research aids in the purification of g-secretase and development of AD therapeutics.